300583 賽托生物
按盤價 
19.140 +2.680 (+16.282%)
19.140 +2.680 (+16.282%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.668 | 2.444 | 2.467 | 2.177 | -10.350 |
| 總資產報酬率 ROA (%) | 0.408 | 1.463 | 1.407 | 1.246 | -6.170 |
| 投入資產回報率 ROIC (%) | 0.457 | 1.662 | 1.651 | 1.456 | -7.223 | 邊際利潤分析 |
| 銷售毛利率 (%) | 25.810 | 22.312 | 20.792 | 22.084 | 11.784 |
| 營業利潤率 (%) | 3.419 | 2.558 | 3.752 | 4.654 | -20.385 |
| 息稅前利潤/營業總收入 (%) | 6.453 | 7.090 | 6.327 | 6.971 | -17.277 |
| 淨利潤/營業總收入 (%) | 2.289 | 3.793 | 3.236 | 2.976 | -20.764 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 67.342 | 66.444 | 93.424 | 94.454 | 62.349 |
| 價值變動淨收益/利潤總額(%) | 51.071 | 6.754 | 16.689 | 7.312 | -4.722 |
| 營業外收支淨額/利潤總額(%) | -2.313 | 38.783 | -2.743 | -3.102 | 3.269 | 償債能力分析 |
| 流動比率 (X) | 1.354 | 1.417 | 1.051 | 1.024 | 1.214 |
| 速動比率 (X) | 0.739 | 0.684 | 0.490 | 0.520 | 0.648 |
| 資產負債率 (%) | 38.232 | 36.256 | 40.886 | 41.677 | 40.472 |
| 帶息債務/全部投入資本 (%) | 29.825 | 28.150 | 32.585 | 32.046 | -- |
| 股東權益/帶息債務 (%) | 227.129 | 245.515 | 204.788 | 209.471 | 204.193 |
| 股東權益/負債合計 (%) | 156.926 | 171.277 | 140.442 | 135.957 | 142.881 |
| 利息保障倍數 (X) | 2.074 | 2.435 | 2.365 | 2.837 | -4.550 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 91.506 | 65.920 | 53.652 | 44.208 | 0.000 |
| 存貨周轉天數 (天) | 300.869 | 240.947 | 197.357 | 204.324 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
